Literature DB >> 3780821

Biliary excretion of ceftriaxone.

W Hayton, K Stoeckel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780821     DOI: 10.1007/bf00871001

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Ceftriaxone: renal and biliary excretion and effect on the colon microflora.

Authors:  A Arvidsson; G Alván; B Angelin; O Borgå; C E Nord
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

Review 2.  Excretory function of the liver.

Authors:  J Reichen; G Paumgartner
Journal:  Int Rev Physiol       Date:  1980

3.  Canalicular bile production in man.

Authors:  D Prandi
Journal:  Eur J Clin Invest       Date:  1975-02       Impact factor: 4.686

4.  Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.

Authors:  W L Hayton; R Schandlik; K Stoeckel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol.

Authors:  J L Boyer; J R Bloomer
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

  5 in total
  6 in total

1.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

Review 2.  Pharmacological properties of cephalosporins.

Authors:  W Christ
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 3.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

6.  Detection of Salmonella Typhi in Bile by Quantitative Real-Time PCR.

Authors:  Ellen E Higginson; Joseph Nkeze; Jasnehta Permala-Booth; Irene N Kasumba; Rosanna Lagos; Juan Carlos Hormazabal; Alexander Byrne; Gad Frankel; Myron M Levine; Sharon M Tennant
Journal:  Microbiol Spectr       Date:  2022-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.